Concepedia

Publication | Open Access

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

DOIFull Paper Access

2.5K

Citations

26

References

2005

Year

Robert S. Bresalier, Robert S. Sandler, Hui Quan, James A. Bolognese, Bettina Oxenius, Kevin Horgan, Christopher Lines, Robert H. Riddell, Dion Morton, Ángel Lanas,
New England Journal of Medicine

Abstract

Among patients with a history of colorectal adenomas, the use of rofecoxib was associated with an increased cardiovascular risk.

References

YearCitations

Page 1